PMID: 8949319Aug 1, 1996Paper

Treatment of myocardial infarction: from the reading of publishing work to everyday prescription

Archives des maladies du coeur et des vaisseaux
S Weber

Abstract

Many therapeutic trials have demonstrated an improvement in the prognosis of myocardial infarction. The practitioner, before changing his prescribing habits, should pose questions to which the authors propose answers. The prescriber should check that the new treatment has been adequately validated by verifying the quality of the therapeutic studies (classical, mega trials such as ISIS or GISSI, metaanalysis). He should also check that a trial population is representative of his own patients (ethnic and social factors, high percentages of patients actually included in the trial compared with those eligible for inclusion). He should insure that his own conditions of practice (patient follow-up, delays and quality of specialised intervention) would provide the same benefit-risk ratio as in the clinical trial. Finally, by analysing patients subgroups or even better, factorial subgroups, and above all, the mode of action of the drugs, he should check that the new treatment may be associated with already established therapeutic modalities. In conclusion, nothing can replace case by case clinical judgment in the application of the results of the literature to everyday practice.

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.